Researchers at Harvard Medical School and Brigham and Women's Hospital have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not. Those with the mutation have a lower risk of diabetes, obesity, heart failure, and even death. The researchers claim that their findings could provide the basis for drug therapies that could mimic the workings of this gene mutation, offering a potential benefit for the millions of people who suffer with diabetes, heart disease and obesity.
Gene mutation slows metabolism lowering diabetes and obesity risk
Love this Post? Spread the Word